Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MediView’s FDA-cleared XR90 platform has been used for successful human procedures such as mediastinal lymph node biopsy. Clinical validation is ongoing with academic and hospital partners, and early commercial adoption has begun in collaboration with major health systems. The platform is cleared as an adjunctive tool for minimally invasive, ultrasound- and CT-guided needle-based procedures for soft tissue and bone.[1][5][6]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MediView.